Article
No interaction between genetic variants and DNA methylation of the ferrochelatase gene in relation to antituberculosis drug-induced liver injury.
Pharmacogenetics and genomics - 1 Mar 2026
Wang Fei, Zhang Meiling, Wu Yu, Cheng Jingru, Chen Ruina, Pan Hongqiu, Lu Lihuan, He Xiaomin, Yi Honggang, Tang Shaowen
Abstract excerpt
OBJECTIVE: The pathogenic mechanisms of antituberculosis drug-induced liver injury (AT-DILI) remain unclear. Isoniazid and rifampicin may lead to hepatic accumulation of protoporphyrin IX in which heme synthesis ferrochelatase (FECH), a key rate-limiting enzyme, potentially plays an important role. This study aimed to investigate the combined effects of FECH gene polymorphisms and promoter methylation on AT-DILI...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
